Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,154 total articles
Opus Genetics, a clinical-stage biopharmaceutical company focused on developing gene therapies to restore vision for inherited retinal diseases, announced it will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026. The company's pipeline includes seven AAV-based gene therapy programs targeting various genetic retinal disorde…
Collegium Pharmaceutical announced that its management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference. The event, scheduled for June 3, 2026, will include a live webcast available on the company’s website. Collegium is a biopharmaceutical company specializing in treatments for central nervous system and …
Galectin Therapeutics presented new analyses from the NAVIGATE trial at the EASL 2026 Congress, showing that belapectin significantly reduces varices development and improves markers of fibrosis and portal hypertension risk in patients with advanced MASH cirrhosis. The data support belapectin's role as a disease-modifying therapy targeting fibrotic…
Live Oak Bank has committed $1 million over five years to The Forward Fund, a North Carolina-based pay-it-forward financing program. The initiative provides zero-percent interest loans to working adults for career training in high-demand fields, fostering workforce upskilling and economic mobility. In its first year, the program issued $2.3 million…
Mesa Laboratories, Inc. announced its fiscal year 2026 financial results, reporting 3.4% revenue growth driven primarily by its Sterilization and Disinfection Control division, offset by declines in Biopharmaceutical Development due to export controls and commercial execution challenges. Operating income rose 13.3%, aided by cost realignment and ba…
Freshworks Inc. releases a report detailing how mid-market companies lose on average 25% of their AI budgets to complexity overhead before achieving returns, with increased workload and integration challenges delaying ROI realization. Despite these hurdles, most mid-market organizations plan to increase AI investments, focusing on AI solutions that…
Annexon, Inc., a biopharmaceutical company focused on targeted immunotherapies for neuroinflammatory diseases, announced that CEO Douglas Love will participate in investor conferences in June 2026 to discuss company progress and strategy. Live webcasts of presentations will be available online.
Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on inhaled therapies for serious respiratory diseases, announced that its management will present an overview of the company at the Jefferies Global Healthcare Conference. The presentation will cover Avalyn's development of inhaled formulations of antifibrotic drugs targeting pu…
Pacira BioSciences reports real-world study findings showing that use of EXPAREL, their non-opioid pain therapy, in outpatient total shoulder arthroplasty patients led to reduced opioid use, fewer opioid-related adverse events, and lower healthcare costs compared to standard analgesia. These findings support the expanding role of non-opioid pain ma…
Mission Produce, Inc., a leading global supplier of fresh Hass avocados and other produce, will release its fiscal second quarter 2026 financial results after market close on June 8, 2026. The company will also hold a conference call and webcast to discuss the results.
GrowGeneration Corp., a major supplier of specialty products for controlled environment agriculture and commercial cultivation, announced its management team's upcoming participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026. CEO Darren Lampert and CFO Gregory Sanders will engage in a Fireside Chat an…
BioVie Inc., a clinical-stage biopharmaceutical company, is hosting a live investor webinar to discuss its investigational oral drug bezisterim for neurological conditions including Parkinson's, Alzheimer's, and Long COVID, as well as progress on BIV201 for advanced liver disease. The company emphasizes the therapeutic potential and multi-billion-d…
Abacus Global Management has entered into a strategic alliance with Manning & Napier, including a minority equity investment of approximately $53 million. This partnership leverages Abacus's proprietary longevity data and actuarial expertise alongside Manning & Napier's wealth management platform, aiming to create enhanced lifespan-based financial …
Cogent Biosciences announced its participation in the Jefferies Global Healthcare Conference scheduled for June 3, 2026, including a live webcast of the presentation. Additionally, the company disclosed inducement equity award grants to six new employees under Nasdaq governance rules, comprising stock options and restricted stock units, to incentiv…
Provident Bank has promoted Jessica Dudick to Senior Vice President, Team Leader of the Monmouth/Ocean Commercial & Industrial lending team. Dudick will manage relationship managers and lending specialists focused on small- to mid-sized business lending and deposit/treasury solutions in New Jersey. She brings over 20 years of experience and will le…
Mineralys Therapeutics, a biopharmaceutical company focused on developing treatments for hypertension and related diseases, announced its management team will participate in the Jefferies 2026 Global Healthcare Conference. They will deliver a corporate presentation, which will be webcast live.
Erasca, Inc., a clinical-stage precision oncology company focused on RAS/MAPK pathway-driven cancers, announced its participation in the Jefferies Global Healthcare Conference. Management will present during a fireside chat and conduct investor meetings, with live and archived webcasts available through the company's website.
NewcelX Ltd., a clinical-stage regenerative medicine company, announced submission of a Pre-IND briefing package to the FDA supporting clinical trial initiation of NCEL-101 combined with tegoprubart for treating type 1 diabetes. The planned therapy aims at enabling durable graft survival without calcineurin inhibitors, potentially offering a functi…
HCW Biologics Inc. has exercised its option to regain exclusive ex vivo commercial rights to two advanced immunotherapeutic reagents, HCW9206 and HCW9201, from Wugen Inc. These reagents show promise for reducing CAR-T therapy manufacturing costs while improving efficacy by enriching long-lived T memory stem cells, potentially enabling more potent a…
VenHub Global, Inc. has opened its second, larger production and assembly facility in Las Vegas, significantly increasing its capacity to manufacture autonomous Smart Stores. This expansion supports faster delivery to meet growing commercial interest and builds on recent strategic agreements, including partnerships with LAX/Metro and Circa Resort &…
Fusion Fuel Green PLC released an investor update video and presentation detailing its strategic progress, financial targets for 2026 and 2027, and plans to acquire up to 100% of Royal Uranium. The company announced an Extraordinary General Meeting for June 8, 2026, to vote on the Royal Uranium acquisition, preferred shares conversion, and a propos…
Allot Ltd., a global provider of cybersecurity and network intelligence solutions, announced management will meet one-on-one with institutional investors during the William Blair Growth Stock Conference from June 2-4, 2026, in Chicago. The company offers comprehensive Security-as-a-Service and network platforms deployed worldwide across service pro…
Avis Budget Group announced its intention to issue $300 million in additional 8% senior notes due 2031 through a private offering. The proceeds, along with existing cash, will be used to redeem part of their 5.75% senior notes due 2027. The offering targets qualified institutional buyers under Rule 144A and is guaranteed by Avis Budget and some US …
FTI Consulting, Inc. announces the appointment of Damon Yousefy as Senior Managing Director in its Transactions practice, focusing on restructuring and bankruptcy tax. With extensive experience in distressed M&A and tax issues, Yousefy's addition is expected to bolster FTI's capabilities to support clients facing financial distress amid geopolitica…
Papa John's International, Inc. announced a global collaboration with Disney and Pixar to celebrate the release of Toy Story 5 in June 2026. The campaign includes themed personal pizzas, limited-edition collectibles, a special in-app game, and a custom-animated Pixar spot. Available in Canada and 42 international markets, this strategic partnership…
